| Metric | შპს იმპექსფარმი | შპს ფარმაცევტული სახლი + | შპს SmartPharm |
|---|---|---|---|
| Growth | |||
| Revenue | ₾102.5m₾109.4m | ₾61.6m₾65.5m | ₾31.6m₾33.9m |
| Revenue growth | -6.4% | -5.8% | -6.8% |
| Profitability | |||
| EBITDA | ₾4.2m₾7.3m | -₾11.7m-₾2.7m | ₾3.3m₾4.0m |
| EBITDA margin | 4.1%6.7% | -18.9%-4.1% | 10.4%11.7% |
| Net profit | ₾153k₾10.2m | -₾11.2m-₾3.1m | |
| ₾2.8m₾4.1m |
| Net margin | 0.1%9.3% | -18.2%-4.8% | 8.8%12.1% |
| Balance sheet | |||
| Total assets | ₾91.0m₾86.7m | ₾66.5m₾48.9m | ₾13.4m₾15.1m |
| Total equity | ₾60.1m₾63.2m | -₾17.3m-₾6.0m | ₾11.6m₾11.0m |
| ROE | 0.3%16.1% | — | 23.9%37.0% |